Drugs / Danggui-Sini granules

Trials 1

202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT04690283 Jan 2021 → Jul 2022 chemotherapy-induced neuropathy, colorectal cancer Nanjing NingQi Medicine Science and Technology Co., Ltd. Unknown No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Danggui-Sini granules ClinicalTrials.gov intervention name — accepted as the source's own label NCT04690283 ↗
Modality Traditional medicine (herbal / TCM) “The intervention relates to a traditional Chinese prescription granules” NCT04690283 ↗
Route Oral “orally take Danggui-Sini granules twice a day” NCT04690283 ↗